Science ❯ Biotechnology ❯ Pharmaceuticals

Clinical Trials

Immunotherapy Cancer Treatments mRNA Technology Product Development Drug Development Veterinary Clinical Trials Phase 3 Trials Cancer Vaccines Neuroreparative Therapies Experimental Treatments

3 ARTICLES

4mo ago

Apogee Secures $1.3 Billion Blackstone Package and Selects Mid‑Dose After Positive Phase 2

The company says the deal plus roughly $1.3 billion in cash should fund late‑stage development through potential approval with Blackstone taking tiered royalties on future sales.

3 ARTICLES

4mo ago

NervGen Prices $60 Million Public Offering of Shares and Warrants